Multiple Products
Biological
CSL Behring
Total Payments
$2.2M
Transactions
1,386
Doctors
386
Companies
2
Payment Trends by Year
| Year | Amount | Transactions | Doctors |
|---|---|---|---|
| 2018 | $217,180 | 705 | 149 |
| 2017 | $2.0M | 681 | 247 |
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Unspecified | $1.4M | 32 | 63.3% |
| Honoraria | $299,213 | 83 | 13.8% |
| Travel and Lodging | $279,261 | 585 | 12.9% |
| Space rental or facility fees (teaching hospital only) | $106,425 | 88 | 4.9% |
| Consulting Fee | $61,525 | 9 | 2.8% |
| Food and Beverage | $47,604 | 575 | 2.2% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $2,484 | 7 | 0.1% |
| Education | $332.64 | 7 | 0.0% |
Payments by Type
Research
$1.4M
32 transactions
General
$796,845
1,354 transactions
Research Studies & Clinical Trials
| Study Name | Sponsor | Amount | Doctors |
|---|---|---|---|
| Development of a US Registry for Previously Untreated Patients (PUPs) with Congenital Hemophilia: A Pilot Study | CSL Behring | $386,700 | 0 |
| Joint Protection Study | CSL Behring | $150,000 | 0 |
| Wear-off Effects of IVIG in Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) Patients Using Daily Grip Strength (GRIPPER) | CSL Behring | $122,557 | 0 |
| Open Label Study of SCIg in myasthenia gravis (MG) | CSL Behring | $106,000 | 0 |
| Evaluating the Immunogenicity of Single Chain Factor VIII | CSL Behring | $100,000 | 0 |
| Differentiation of Patients with Type 1 von Willebrands | CSL Behring | $80,580 | 0 |
| PCC vs. FFP for Post Cardiopulmonary Bypass Coagulopathy and Bleeding | CSL Behring | $54,020 | 0 |
| Safety of Oral Anticoagulation Registry (SOAR) | CSL Behring | $54,000 | 0 |
| A Longitudinal, Oberservational study of previously treated Hemophilia Patients (PTPs) Switching Coagulation Replacement Factor Products | CSL Behring | $50,000 | 0 |
| A study of subcutaneous immunoglobulin as chronic treatment for patients with chronic inflammatory demyelinating polyneuropathy | CSL Behring | $48,500 | 0 |
| A Retrospective Study of the Utility of Spirometry to Manage Immunoglobulin Replacement Dosage in Primary Antibody Deficiency | CSL Behring | $40,000 | 0 |
| A Retrospective, Observational Study of the Utility of Spirometry to Manage Immunoglobulin Replacement Dosage in Primary Antibody Deficiency | CSL Behring | $40,000 | 0 |
| Extension Study of Maintenance Treatment With Subcutaneous Immunoglobulin (IgPro20) for Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) | CSL Behring | $37,934 | 0 |
| A Double-blind, Placebo Controlled study of Intravenous Immunoglobulin for HIV Associated Myelopathy | CSL Behring | $37,667 | 1 |
| Pathogenesis of hereditary angioedema type III | CSL Behring | $35,000 | 0 |
| Simultaneous detection of TREC's and KREC's in newborn screening DNA isolated from Gurthrie Card dried blood spots | CSL Behring | $15,000 | 0 |
| Costs of Illness and Impact of von Willebrand Disease: A Pilot Study | CSL Behring | $10,000 | 0 |
| Thrombocytopenia as initial presentation of IKAROS deficiency associated with novel IKZF1 mutation | CSL Behring | $4,162 | 0 |
Top Doctors Receiving Payments for Multiple Products
| Doctor | Specialty | Location | Total | Records |
|---|---|---|---|---|
| Unknown | — | Pittsburgh, PA | $1.4M | 119 |
| , M.D | Specialist | Dallas, TX | $42,026 | 14 |
| , M.D | Neurology | New York, NY | $37,667 | 1 |
| , M.D | Cardiovascular Disease | Detroit, MI | $33,693 | 7 |
| , M.D | Pediatric Hematology-Oncology | Madera, CA | $25,433 | 26 |
| , MD | Internal Medicine | San Francisco, CA | $24,471 | 7 |
| , MD | Orthopaedic Surgery of the Spine | Raleigh, NC | $23,889 | 15 |
| , M.D | Nephrology | Indianapolis, IN | $23,745 | 7 |
| , MD | Allergy & Immunology | San Diego, CA | $21,695 | 14 |
| , MD | Hematology & Oncology | Tampa, FL | $21,030 | 19 |
| , M.D | Cardiovascular Disease | Roxbury Crossing, MA | $18,487 | 6 |
| , DO | Allergy & Immunology | Hershey, PA | $18,008 | 15 |
| , MD | Orthopaedic Surgery of the Spine | Paducah, KY | $15,767 | 7 |
| Clint Hill | — | Paducah, KY | $14,929 | 11 |
| , MD | Anesthesiology | Durham, NC | $14,272 | 10 |
| , MD | Orthopaedic Surgery | Middletown, CT | $12,805 | 7 |
| , MD | Emergency Medical Services | Austin, TX | $11,873 | 5 |
| , MD, PHD | Emergency Medicine | Boston, MA | $11,869 | 5 |
| , M.D | Surgery | Detroit, MI | $11,611 | 7 |
| , MD | Allergy & Immunology | Los Angeles, CA | $11,244 | 11 |
| , MD | Pulmonary Disease | Charleston, SC | $9,310 | 8 |
| , MD | Hematology & Oncology | Seattle, WA | $8,949 | 5 |
| , MD | Specialist | Jacksonville, FL | $8,064 | 11 |
| , MD | Allergy | San Diego, CA | $7,764 | 8 |
| , M.D | Neurological Surgery | Greensboro, NC | $7,567 | 19 |
Ad
Manufacturing Companies
- CSL Behring $1.9M
- Alphatec Spine, Inc $219,483
Product Information
- Type Biological
- Total Payments $2.2M
- Total Doctors 386
- Transactions 1,386
About Multiple Products
Multiple Products is a biological associated with $2.2M in payments to 386 healthcare providers, recorded across 1,386 transactions in the CMS Open Payments database. The primary manufacturer is CSL Behring.
Payment data is available from 2017 to 2018. In 2018, $217,180 was paid across 705 transactions to 149 doctors.
The most common payment nature for Multiple Products is "Unspecified" ($1.4M, 63.3% of total).
Multiple Products is associated with 18 research studies, including "Development of a US Registry for Previously Untreated Patients (PUPs) with Congenital Hemophilia: A Pilot Study" ($386,700).